Can modulate genetic expression when functionalized with specific ligands
Can mimic natural signaling pathways when designed to target specific receptor
Nanoscale delivery systems
Can be engineered to modulate immune responses for targeted therapy
Have the potential to modulate genetic expression for therapeutic purpose
Can be designed to mimic natural signaling pathways for targeted drug delivery
Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system
Used for molecular detection in immune-related research
Can be employed to modulate genetic expression through gene editing
Utilized to study and manipulate natural signaling pathways within cells
Declarations
Author Contributions
AVS, PB, and AKU equally contributed to: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. AP, JU, and JB: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. VT, DG, and MT: Validation, Writing—review & editing, Supervision. RM and PZ: Supervision, Project administration. All authors read and approved the submitted version.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent to publication
Not applicable.
Availability of data and materials
The data supporting the findings of this study are available upon request.
Funding
This study was funded by the application of multivalent biomineralized nanostructures as a modular strategy for targeting colorectal cancer [CDIRCC-2024-468] by Qatar University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Nanomedicine—challenge and perspectives.Angew Chem Int Ed Engl. 2009;48:872−97. [DOI] [PubMed] [PMC]
Hassan S, Singh AV. Biophysicochemical perspective of nanoparticle compatibility: a critically ignored parameter in nanomedicine.J Nanosci Nanotechnol. 2014;14:402−14. [DOI] [PubMed]
Singh AV, Ansari MHD, Laux P, Luch A. Micro-nanorobots: important considerations when developing novel drug delivery platforms.Expert Opin Drug Deliv. 2019;16:1259−75. [DOI] [PubMed]
Rai M, Singh AV, Paudel N, Kanase A, Falletta E, Kerkar P, et al. Herbal concoction unveiled: a computational analysis of phytochemicals’ pharmacokinetic and toxicological profiles using novel approach methodologies (NAMs).Curr Res Toxicol. 2023;5:100118. [DOI] [PubMed] [PMC]
Singh AV, Chandrasekar V, Laux P, Luch A, Dakua SP, Zamboni P, et al. Micropatterned neurovascular interface to mimic the blood−brain barrier’s neurophysiology and micromechanical function: a BBB-on-chip model.Cells. 2022;11:2801. [DOI] [PubMed] [PMC]
Singh AV, Chandrasekar V, Janapareddy P, Mathews DE, Laux P, Luch A, et al. Emerging application of nanorobotics and artificial intelligence to cross the BBB: advances in design, controlled maneuvering, and targeting of the barriers.ACS Chem Neurosci. 2021;12:1835−53. [DOI] [PubMed]
Ansari MY, Chandrasekar V, Singh AV, Dakua SP. Re-routing drugs to blood brain barrier: a comprehensive analysis of machine learning approaches with fingerprint amalgamation and data balancing.IEEE Access. 2023;11:9890−906.
Zhang X, Centurion F, Misra A, Patel S, Gu Z. Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment.Adv Drug Deliv Rev. 2023;194:114709. [DOI] [PubMed]
Salvatori F, D’Aversa E, Serino ML, Singh AV, Secchiero P, Zauli G, et al. miRNAs epigenetic tuning of wall remodeling in the early phase after myocardial infarction: a novel epidrug approach.Int J Mol Sci. 2023;24:13268. [DOI] [PubMed] [PMC]
Singh SL, Chauhan K, Bharadwaj AS, Kishore V, Laux P, Luch A, et al. Polymer translocation and nanopore sequencing: a review of advances and challenges.Int J Mol Sci. 2023;24:6153. [DOI] [PubMed] [PMC]
Dwivedi M, Singh SL, Bharadwaj AS, Kishore V, Singh AV. Self-assembly of DNA-grafted colloids: a review of challenges.Micromachines (Basel). 2022;13:1102. [DOI] [PubMed] [PMC]
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects.J Nanobiotechnology. 2018;16:71. [DOI] [PubMed] [PMC]
Mahon E, Salvati A, Baldelli Bombelli F, Lynch I, Dawson KA. Designing the nanoparticle-biomolecule interface for “targeting and therapeutic delivery”.J Control Release. 2012;161:164−74. [DOI] [PubMed]
Singh AV, Kayal A, Malik A, Maharjan RS, Dietrich P, Thissen A, et al. Interfacial water in the SARS spike protein: investigating the interaction with human ACE2 receptor and in vitro uptake in A549 cells.Langmuir. 2022;38:7976−88. [DOI] [PubMed]
Saallah S, Lenggoro IW. Nanoparticles carrying biological molecules: recent advances and applications.KONA Powder Part J. 2018;35:89−111. [DOI]
Singh AV, Rosenkranz D, Ansari MHD, Singh R, Kanase A, Singh SP, et al. Artificial intelligence and machine learning empower advanced biomedical material design to toxicity prediction.Adv Intell Syst. 2020;2:2000084. [DOI]
Mudshinge SR, Deore AB, Patil S, Bhalgat CM. Nanoparticles: emerging carriers for drug delivery.Saudi Pharm J. 2011;19:129−41. [DOI] [PubMed] [PMC]
Tripathi D, Ray P, Singh AV, Kishore V, Singh SL. Durability of slippery liquid-infused surfaces: challenges and advances.Coatings. 2023;13:1095. [DOI]
Lu H, Zhang S, Wang J, Chen Q. A Review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems.Front Nutr. 2021;8:783831. [DOI] [PubMed] [PMC]
Singh AV, Hosseinidoust Z, Park BW, Yasa O, Sitti M. Microemulsion-based soft bacteria-driven microswimmers for active cargo delivery.ACS Nano. 2017;11:9759−69. [DOI] [PubMed]
Kumar R, Dkhar DS, Kumari R, Divya, Mahapatra S, Dubey VK, et al. Lipid based nanocarriers: production techniques, concepts, and commercialization aspect.J Drug Delivery Sci Technol. 2022;74:103526. [DOI]
Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles─from liposomes to mrna vaccine delivery, a landscape of research diversity and advancement.ACS Nano. 2021;15:16982−7015. [DOI] [PubMed]
Plaza-Oliver M, Santander-Ortega MJ, Lozano MV. Current approaches in lipid-based nanocarriers for oral drug delivery.Drug Deliv Transl Res. 2021;11:471−97. [DOI] [PubMed] [PMC]
Singh AV, Laux P, Luch A, Sudrik C, Wiehr S, Wild AM, et al. Review of emerging concepts in nanotoxicology: opportunities and challenges for safer nanomaterial design.Toxicol Mech Methods. 2019;29:378−87. [DOI] [PubMed]
Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Scale-up polymeric-based nanoparticles drug delivery systems: development and challenges.OpenNano. 2022;7:100048. [DOI]
Singh AV, Alapan Y, Jahnke T, Laux P, Luch A, Aghakhani A, et al. Seed-mediated synthesis of plasmonic gold nanoribbons using cancer cells for hyperthermia applications.J Mater Chem B. 2018;6:7573−81. [DOI] [PubMed]
Singh AV, Jahnke T, Wang S, Xiao Y, Alapan Y, Kharratian S, et al. Anisotropic gold nanostructures: optimization via in silico modeling for hyperthermia.ACS Appl Nano Mater. 2018;1:6205−16. [DOI]
Singh AV, Jahnke T, Kishore V, Park BW, Batuwangala M, Bill J, et al. Cancer cells biomineralize ionic gold into nanoparticles-microplates via secreting defense proteins with specific gold-binding peptides.Acta Biomater. 2018;71:61−71. [DOI] [PubMed]
Su S, M Kang P. Recent advances in nanocarrier-assisted therapeutics delivery systems.Pharmaceutics. 2020;12:837. [DOI] [PubMed] [PMC]
Zielińska A, Carreiró F, Oliveira AM, Neves A, Pires B, Venkatesh DN, et al. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology.Molecules. 2020;25:3731. [DOI] [PubMed] [PMC]
Begines B, Ortiz T, Pérez-Aranda M, Martínez G, Merinero M, Argüelles-Arias F, et al. Polymeric nanoparticles for drug delivery: recent developments and future prospects.Nanomaterials (Basel). 2020;10:1403. [DOI] [PubMed] [PMC]
Chandrasekar V, Singh AV, Maharjan RS, Dakua SP, Balakrishnan S, Dash S, et al. Perspectives on the technological aspects and biomedical applications of virus-like particles/nanoparticles in reproductive biology: insights on the medicinal and toxicological outlook.Adv NanoBiomed Res. 2022;2:2200010. [DOI]
Valcourt DM, Harris J, Riley RS, Dang M, Wang J, Day ES. Advances in targeted nanotherapeutics: from bioconjugation to biomimicry.Nano Res. 2018;11:4999−5016. [DOI] [PubMed] [PMC]
Singh AV, Maharjan RS, Kanase A, Siewert K, Rosenkranz D, Singh R, et al. Machine-learning-based approach to decode the influence of nanomaterial properties on their interaction with cells.ACS Appl Mater Interfaces. 2021;13:1943−55. [DOI] [PubMed]
Cremers GAO, Rosier BJHM, Meijs A, Tito NB, van Duijnhoven SMJ, van Eenennaam H, et al. Determinants of ligand-functionalized DNA nanostructure–cell interactions.J Am Chem Soc. 2021;143:10131−42. [DOI] [PubMed] [PMC]
Bhatti R, Shakeel H, Malik K, Qasim M, Khan MA, Ahmed N, et al. Inorganic nanoparticles: toxic effects, mechanisms of cytotoxicity and phytochemical interactions.Adv Pharm Bull. 2022;12:757−62. [DOI] [PubMed] [PMC]
Singh AV, Romeo A, Scott K, Wagener S, Leibrock L, Laux P, et al. Emerging technologies for in vitro inhalation toxicology.Adv Healthc Mater. 2021;10:2100633. [DOI] [PubMed]
Singh AV, Maharjan RS, Kromer C, Laux P, Luch A, Vats T, et al. Advances in smoking related in vitro inhalation toxicology: a perspective case of challenges and opportunities from progresses in lung-on-chip technologies.Chem Res Toxicol. 2021;34:1984−2002. [DOI] [PubMed]
Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, et al. Synthetic peptides that antagonize the angiotensin-converting enzyme-2 (ACE-2) interaction with SARS-CoV-2 receptor binding spike protein.J Med Chem. 2022;65:2836−47. [DOI] [PubMed] [PMC]
Vadevoo SMP, Gurung S, Lee HS, Gunassekaran GR, Lee SM, Yoon JW, et al. Peptides as multifunctional players in cancer therapy.Exp Mol Med. 2023;55:1099−109. [DOI] [PubMed] [PMC]
Ng KK, Zheng G. Molecular interactions in organic nanoparticles for phototheranostic applications.Chem Rev. 2015;115:11012−42. [DOI] [PubMed]
Maleki R, Rezvantalab S, Shahbazi MA. Role of molecular simulation in the future of nanomedicine.Nanomedicine (Lond). 2021;16:2133−6. [DOI] [PubMed]
Singh AV, Laux P, Luch A, Balkrishnan S, Dakua SP. Bottom-UP assembly of nanorobots: extending synthetic biology to complex material design.Front Nanosci Nanotechnol. 2019;5:1−2. [DOI]
Govender R, Abrahmsén-Alami S, Larsson A, Folestad S. Therapy for the individual: towards patient integration into the manufacturing and provision of pharmaceuticals.Eur J Pharm Biopharm. 2020;149:58−76. [DOI] [PubMed]
Alghamdi MA, Fallica AN, Virzì N, Kesharwani P, Pittalà V, Greish K. The promise of nanotechnology in personalized medicine.J Pers Med. 2022;12:673. [DOI] [PubMed] [PMC]
Singh AV, Varma M, Laux P, Choudhary S, Datusalia AK, Gupta N, et al. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review.Arch Toxicol. 2023;97:963−79. [DOI] [PubMed] [PMC]
Singh AV, Bansod G, Mahajan M, Dietrich P, Singh SP, Rav K, et al. Digital transformation in toxicology: improving communication and efficiency in risk assessment.ACS Omega. 2023;8:21377−90. [DOI] [PubMed] [PMC]
Singh AV, Dad Ansari MH, Dayan CB, Giltinan J, Wang S, Yu Y, et al. Multifunctional magnetic hairbot for untethered osteogenesis, ultrasound contrast imaging and drug delivery.Biomaterials. 2019;219:119394. [DOI] [PubMed]
Singh AV, Jungnickel H, Leibrock L, Tentschert J, Reichardt P, Katz A, et al. ToF-SIMS 3D imaging unveils important insights on the cellular microenvironment during biomineralization of gold nanostructures.Sci Rep. 2020;10:261. [DOI] [PubMed] [PMC]
Malik S, Muhammad K, Waheed Y. Nanotechnology: a revolution in modern industry.Molecules. 2023;28:661. [DOI] [PubMed] [PMC]
Singh AV, Ansari MHD, Rosenkranz D, Maharjan RS, Kriegel FL, Gandhi K, et al. Artificial intelligence and machine learning in computational nanotoxicology: unlocking and empowering nanomedicine.Adv Healthc Mater. 2020;9:e1901862. [DOI] [PubMed]
Tsai-hsuan Ku S. Forming interdisciplinary expertise: one organization’s journey on the road to translational nanomedicine.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4:366−77. [DOI] [PubMed] [PMC]
Löffler B. Editorial: moving towards interdisciplinary collaboration in clinical nanomedicine.Eur J Nanomed. 2008;1:3−5. [DOI]
Kulkarni PG, Paudel N, Magar S, Santilli MF, Kashyap S, Baranwal AK, et al. Overcoming challenges and innovations in orthopedic prosthesis design: an interdisciplinary perspective.Biomed Mater Devices. 2024;2:58−69. [DOI] [PubMed] [PMC]
Rai M, Paudel N, Sakhrie M, Gemmati D, Khan IA, Tisato V, et al. Perspective on quantitative structure−toxicity relationship (qstr) models to predict hepatic biotransformation of xenobiotics.Livers. 2023;3:448−62. [DOI]
Fornaguera C, García-Celma MJ. Personalized nanomedicine: a revolution at the nanoscale.J Pers Med. 2017;7:12. [DOI] [PubMed] [PMC]
Singh AV, Shelar A, Rai M, Laux P, Thakur M, Donskyi I, et al. Harmonizing risks and rewards: nano-QSAR for agricultural nanomaterials.J Agric Food Chem. 2024;72:2835−52.Erratum in: J Agric Food Chem. 2024;72:8284. [DOI] [PubMed]
Singh AV, Varma M, Rai M, Singh SP, Bansod G, Laux P, et al. Advancing predictive risk assessment of chemicals via integrating machine learning, computational modeling, and chemical/nano-quantitative structure-activity relationship approaches.Adv Intell Syst. 2024:2300366. [DOI]
